Stereotaxis (STXS) Retained Earnings (2010 - 2026)
Stereotaxis (STXS) posted quarterly Retained Earnings of -$589.2 million for Q1 2026, down 3.83% year-over-year from -$612.7 million in Q1 2025, and down 1.0% quarter-over-quarter from -$583.4 million in Q4 2025.
Stereotaxis (STXS) Retained Earnings (2010 - 2026) Analysis & Trends
Stereotaxis (STXS) has reported Retained Earnings for 17 consecutive years, with -$589.2 million the latest figure, recorded in Q1 2026.
- In Q1 2026, Retained Earnings fell 3.83% year-over-year to -$589.2 million; the TTM figure through Mar 2026 stood at -$589.2 million (down 3.83% YoY), while the FY2025 annual figure was -$583.4 million, down 202.72% from the prior year.
- Retained Earnings eased to -$589.2 million in Q1 2026 per STXS's latest filing, from -$583.4 million in the prior quarter.
- Across five years, Retained Earnings topped out at $584.2 million in Q3 2025 and bottomed at -$589.2 million in Q1 2026.
- Historically, Retained Earnings has averaged -$32.1 million across 5 years, with a median of -$502.8 million in 2022.
- Annual changes were most pronounced in 2022 — Retained Earnings jumped 208.98% — and 2025, when it plunged 202.72%.
- Stereotaxis' Retained Earnings stood at $543.4 million in 2022, then slumped by 198.94% to -$537.7 million in 2023, then surged by 205.63% to $567.9 million in 2024, then slumped by 202.72% to -$583.4 million in 2025, then dropped by 1.0% to -$589.2 million in 2026.
- Business Quant data shows STXS's Retained Earnings at -$589.2 million in Q1 2026, -$583.4 million in Q4 2025, and $584.2 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Retained Earnings (Qtr) |
|---|---|---|---|---|---|
| 1 | Intuitive Surgical | 134.13 Bn | 128.91 Bn | 1.96 Bn | 6.84 Bn |
| 2 | Becton Dickinson | 52.76 Bn | 51.90 Bn | 2.32 Bn | 17.51 Bn |
| 3 | Alcon | 35.81 Bn | 34.46 Bn | 1.68 Bn | - |
| 4 | Resmed | 33.72 Bn | 32.25 Bn | 861.22 Mn | 7.26 Bn |
| 5 | Medline | 29.38 Bn | 26.70 Bn | 2.22 Bn | 11.40 Bn |
| 6 | West Pharmaceutical Services | 25.00 Bn | 24.57 Bn | 329.20 Mn | 4.62 Bn |
| 7 | Solventum | 15.46 Bn | 15.06 Bn | 1.29 Bn | 3.92 Bn |
| 8 | Cooper Companies | 14.88 Bn | 14.74 Bn | 735.40 Mn | 7.70 Bn |
| 9 | Baxter International | 13.58 Bn | 11.43 Bn | 1.03 Bn | 13.81 Bn |
| 10 | Stereotaxis | 141.91 Mn | 127.29 Mn | 3.79 Mn | 603.70 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -589.23 Mn |
| Dec 31, 2025 | -583.37 Mn |
| Sep 30, 2025 | 584.22 Mn |
| Jun 30, 2025 | -571.40 Mn |
| Mar 31, 2025 | -567.50 Mn |
| Dec 31, 2024 | 567.93 Mn |
| Sep 30, 2024 | -554.21 Mn |
| Jun 30, 2024 | -548.02 Mn |
| Mar 31, 2024 | 556.88 Mn |
| Dec 31, 2023 | -537.68 Mn |
| Sep 30, 2023 | 551.48 Mn |
| Jun 30, 2023 | 548.78 Mn |
| Mar 31, 2023 | -522.31 Mn |
| Dec 31, 2022 | 543.44 Mn |
| Sep 30, 2022 | 540.71 Mn |
| Jun 30, 2022 | 537.96 Mn |
| Mar 31, 2022 | -502.76 Mn |
| Dec 31, 2021 | -498.68 Mn |
| Sep 30, 2021 | 530.02 Mn |
| Jun 30, 2021 | 527.29 Mn |